Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
12:12am, Thursday, 16'th May 2024
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financi
Pfizer: Best Trading Momentum Since 2021 And 6% Yield
08:45am, Wednesday, 15'th May 2024
Pfizer: Best Trading Momentum Since 2021 And 6% Yield
3 No-Brainer Stocks to Buy With $500 Right Now
05:21am, Wednesday, 15'th May 2024
Stocks have handily outperformed all other asset classes in annualized returns over the last century. Most online brokers have made it easier than ever for retail investors to put their money to work
Final Trades: Pfizer, Vertex, Freeport-McMoran and Qualcomm
01:55pm, Tuesday, 14'th May 2024
The Investment Committee give you their top stocks to watch for the second half.
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
10:07am, Tuesday, 14'th May 2024
The healthcare sector has attractive stocks for any investment strategy. Pfizer has an impressive product pipeline and an attractive valuation as well.
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
06:30am, Tuesday, 14'th May 2024
Biotechnology is an interesting place to look if you're looking for growth and are not put off by severe levels of volatility. Undoubtedly, there's a bit of speculative zest regarding some of the smal
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
08:00am, Monday, 13'th May 2024
16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers TOKYO , May 13, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and
3 Stocks That Suddenly Drew in Options Traders
07:46am, Monday, 13'th May 2024
Options are complicated and not for the faint of heart. While some investors may use them to take on irresponsible leverage levels on their minor positions, others could use them to express their pred
Pfizer's next move: Can it break above $30?
06:27am, Monday, 13'th May 2024
Pfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. However, recent developments suggest a potential turnaround for the pharm
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
03:07am, Monday, 13'th May 2024
For years, Pfizer's dividend yield averaged roughly 3.6%. Following a prolonged share price slide, the dividend yield is now approaching 6%.
3 Dividend Stocks for May 2024
11:00am, Sunday, 12'th May 2024
The dividend prospects of three firms with wide or narrow Morningstar Economic Moat Ratings.
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
08:29am, Sunday, 12'th May 2024
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business
A Struggling Pfizer Looks for Help From a Wall Streeter
08:02pm, Friday, 10'th May 2024
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn't recommended the stock in over a decade. But Andrew Baum has something Pfizer
2 Beaten-Down Stocks to Buy and Hold for 10 Years
09:45am, Friday, 10'th May 2024
Bristol Myers and Pfizer have experienced declining sales lately. However, both companies are rejuvenating their lineups.
How To Build An 8% Yielding SWAN Portfolio With 10 Blue Chips
07:00am, Friday, 10'th May 2024
High-yield dividend investing is a popular retirement strategy for its steady income, lower volatility, and potential to outperform the market. JPMorgan Equity Premium Income ETF offers an 8% yield bu
